Voyager Therapeutics (VYGR) Net Margin Growth (1y) (2016 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) Net Margin Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 603.00 |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | 2.25 Mn |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 13,865.00 |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 6,876.00 |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | -67,094.00 |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | -2.38 Mn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 314,889.00 |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | -3,345.00 |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 371.00 |
| 10 | Voyager Therapeutics | 215.07 Mn | 98.73 Mn | - | -12,282.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12,282.00 |
| Mar 31, 2026 | -59,725.00 |
| Dec 31, 2025 | 53,489.00 |
| Sep 30, 2025 | -17,143.00 |
| Jun 30, 2025 | -60,770.00 |
| Mar 31, 2025 | -41,919.00 |
| Dec 31, 2024 | -61,195.00 |
| Sep 30, 2024 | 52,464.00 |
| Jun 30, 2024 | 41,896.00 |
| Mar 31, 2024 | -14,049.00 |
| Dec 31, 2023 | -146,164.00 |
| Sep 30, 2023 | -60,425.00 |
| Jun 30, 2023 | 222,753.00 |
| Mar 31, 2023 | 332,240.00 |
| Dec 31, 2022 | 150,392.00 |
| Sep 30, 2022 | 173,905.00 |
| Jun 30, 2022 | -57,405.00 |
| Mar 31, 2022 | -284,652.00 |
| Dec 31, 2021 | 26,396.00 |
| Sep 30, 2021 | -176,880.00 |